DISODIUM (.ALPHA.S,2R,5Z)-4-CARBOXY-2,5-DIHYDRO-5-(4-HYDROXYBUTYLIDENE)-.ALPHA.-((1R)-1-HYDROXYETHYL)-2-THIAZOLEACETIC ACID
UNII J6KA638MRD

Substance Identification & Data

This profile provides standardized clinical and technical data for Disodium (.alpha.s,2r,5z)-4-carboxy-2,5-dihydro-5-(4-hydroxybutylidene)-.alpha.-((1r)-1-hydroxyethyl)-2-thiazoleacetic Acid, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J6KA638MRD.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 130609-10-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
J6KA638MRD
CAS Registry Number
130609-10-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DISODIUM (.ALPHA.S,2R,5Z)-4-CARBOXY-2,5-DIHYDRO-5-(4-HYDROXYBUTYLIDENE)-.ALPHA.-((1R)-1-HYDROXYETHYL)-2-THIAZOLEACETIC ACID
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C12H15NO6S.2Na
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
UGZVTVHLDCCTCN-DHIRNNANSA-L
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
14659036
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C[C@H]([C@H]([C@]1([H])N=C(/C(=C/CCCO)/S1)C(=O)[O-])C(=O)[O-])O.[Na+].[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Disodium (.alpha.s,2r,5z)-4-carboxy-2,5-dihydro-5-(4-hydroxybutylidene)-.alpha.-((1r)-1-hydroxyethyl)-2-thiazoleacetic Acid. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

2-THIAZOLEACETIC ACID, 4-CARBOXY-2,5-DIHYDRO-5-(4-HYDROXYBUTYLIDENE)-.ALPHA.-((1R)-1-HYDROXYETHYL)-, DISODIUM SALT, (.ALPHA.S,2R,5Z)-
2-THIAZOLEACETIC ACID, 4-CARBOXY-2,5-DIHYDRO-5-(4-HYDROXYBUTYLIDENE)-.ALPHA.-(1-HYDROXYETHYL)-, DISODIUM SALT, (2R-(2R*(S*(R*)),5Z))-
DISODIUM (.ALPHA.S,2R,5Z)-4-CARBOXY-2,5-DIHYDRO-5-(4-HYDROXYBUTYLIDENE)-.ALPHA.-((1R)-1-HYDROXYETHYL)-2-THIAZOLEACETIC ACID
DISODIUM (2R,5Z)-2-((1S,2R)-1-CARBOXYLATO-2-HYDROXYPROPYL)-5-(4-HYDROXYBUT-1-YLIDENE)-2,5-DIHYDRO-1,3-THIAZOLE-4-CARBOXYLATE
DISODIUM (2R,5Z)-2-((1S,2R)-1-CARBOXYLATO-2-HYDROXYPROPYL)-5-(4-HYDROXYBUTYLIDENE)-2,5-DIHYDRO-1,3-THIAZOLE-4-CARBOXYLATE

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound